Systematic review and Meta-analysis of efficacy and safety of dienogest in treatment of endometriosis

Abstract

Condition tags

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (41)

• A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
• Clinical dynamics of Dienogest for the treatment of endometriosis: from bench to bedside via openalex
• Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial via openalex
• Consensus on current management of endometriosis via openalex
• Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials via openalex
• Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study via openalex
• Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis via openalex
• Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β via openalex
• Dienogest inhibits Toll-like receptor 4 expression induced by costimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells via openalex
• Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
• Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
• Dienogest reduces proliferation, NGF expression and nerve fiber density in human adenomyosis via openalex
• Dienogest Versus Leuprolide Acetate for Recurrent Pelvic Pain Following Laparoscopic Treatment of Endometriosis via openalex
• Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model via openalex
• Effects of Dienogest on Surgically Induced Endometriosis in Rats after Repeated Oral Administration via openalex
• Effects of ranibizumab and zoledronic acid on endometriosis in a rat model via openalex
• Endometriosis via openalex
• Endometriosis: pathogenesis and treatment via openalex
• ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
• Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial via openalex
• Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study via openalex
• Exploratory study of pre‐surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts via openalex
• Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
• Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study via openalex
• <p>Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain</p> via openalex
• Optimizing Gonadotropin-Releasing Hormone Agonist Therapy in Women with Endometriosis via openalex
• Ovulation‐Inhibiting Effects of Dienogest in a Randomized, Dose‐Controlled Pharmacodynamic Trial of Healthy Women via openalex
• Pathogenesis and pathophysiology of endometriosis via openalex
• Progesterone and progestational compounds attenuate tumor necrosis factor alpha–induced interleukin-8 production via nuclear factor kappaB inactivation in endometriotic stromal cells via openalex
• Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest via openalex
• Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment via openalex
• Rethinking mechanisms, diagnosis and management of endometriosis via openalex
• The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey via openalex
• Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials via openalex
• Women's experiences of endometriosis: a systematic review and synthesis of qualitative research via openalex
• W2012076119 via openalex
• W2101417341 via openalex
• W2021687464 via openalex
• W2166050085 via openalex
• W2079421112 via openalex
• W2996101359 via openalex

Cited by (4)

• Evaluation of the efficacy and tolerability of 4 mg dienogest in women with adenomyosis and BMI >30 2025
• Innovations in the diagnosis and treatment of endometriosis: from the current advancements to a future outlook: A review 2025
• The Efficacy of Medical Treatment on Endometrioma: A Systematic Review and Meta-Analysis 2024
• Efficacy and Safety of Dienogest in the Management of Women with Endometriosis; Systematic Review and Meta-Analysis 2023

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00